TASTE: One-year follow-up results

Authors

  • Mahmoud Farouk Elmahdy Aswan Heart Center, Division of Cardiology, Aswan, Egypt
  • Ahmed Mohamed ElGuindy Aswan Heart Center, Division of Cardiology, Aswan, Egypt
  • David Antoniucci Head of Cardiology Department, Careggi Hospital, Florence, Italy

Abstract

[first paragraph of article]

Using thrombus aspiration devices during primary percutaneous coronary intervention (PCI) in the setting of ST-segment elevation myocardial infarction (STEMI) is a highly debatable issue. In 2013, after the announcement of the Thrombus Aspiration in ST-Elevation Myocardial Infarction in Scandinavia trial (TASTE) short term outcomes, more confusion was added to this hot topic. The main, but not only, concern about TASTE was the short-term follow-up period of just 30 days. So, can the one-year follow-up results help in solving this debate?

Downloads

Published

2017-08-22

Issue

Vol. 2015 No. 2 (2015)

Section

Lessons from the trials

License

This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.